Aclaris Therapeutics Overview
Aclaris Therapeutics Discounted Cash Flow
DCF Analysis for ACRS.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.96
Current Fair Value
$-0.96
↓ 122.0% Downside
Overvalued by 122.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison